medroxyprogesterone acetate 2.5 MG Oral Tablet
- RxCUI
- 1000135
- RxNorm name
- medroxyprogesterone acetate 2.5 MG Oral Tablet
- Display name
- medroxyPROGESTERone (Oral Pill)
- Full name
- medroxyprogesterone acetate 2.5 MG Oral Tablet
- Term type
- SCD
- Status
- Active
- Strength
- 2.5 mg
- Dose form
- Tab
- Route
- Oral Pill
- Updated
- 2026-10-21 07:26:33
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 092010
- Active start
- 092010
- Multiple ingredient
- NO
- Branded
- NO
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| medroxyprogesterone acetate | 2.5 MG / 1 EACH | medroxyprogesterone | medroxyprogesterone acetate |
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Oral Tablet | 317541 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| medroxyprogesterone | 6691 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| PRESCRIBABLE | Y | 1 | ATTRIBUTES |
| RXNAV_STR | medroxyPROGESTERone acetate 2.5 MG Oral Tablet | 1 | NAMES |
| RxNorm Name | medroxyprogesterone acetate 2.5 MG Oral Tablet | 1 | NAMES |
| TTY | SCD | 1 | ATTRIBUTES |
| SPL_SET_ID | 7 | CODES | |
| RxCUI | 1000135 | 1 | CODES |
| MMSL_CODE | 2 | CODES |
FDA NDC Products And Packages#
| Package NDC | Product NDC | Name | Labeler | Application |
|---|---|---|---|---|
| 0555-0872-02 | 0555-0872 | Medroxyprogesterone Acetate Medroxyprogesterone Acetate | Teva Pharmaceuticals USA, Inc. | ANDA040159 |
| 0555-0872-04 | 0555-0872 | Medroxyprogesterone Acetate Medroxyprogesterone Acetate | Teva Pharmaceuticals USA, Inc. | ANDA040159 |
| 50090-0490-2 | 50090-0490 | Medroxyprogesterone Acetate Medroxyprogesterone Acetate | A-S Medication Solutions | ANDA040159 |
| 59762-0055-1 | 59762-0055 | medroxyprogesterone acetate medroxyprogesterone acetate | Mylan Pharmaceuticals Inc. | NDA011839 |
| 59762-0055-2 | 59762-0055 | medroxyprogesterone acetate medroxyprogesterone acetate | Mylan Pharmaceuticals Inc. | NDA011839 |
| 63629-8825-1 | 63629-8825 | Medroxyprogesterone Acetate Medroxyprogesterone Acetate | Bryant Ranch Prepack | ANDA040159 |
| 67046-1480-3 | 67046-1480 | Medroxyprogesterone Acetate Medroxyprogesterone Acetate | Coupler LLC | ANDA040159 |
| 70518-4666-0 | 70518-4666 | Medroxyprogesterone Acetate Medroxyprogesterone Acetate | REMEDYREPACK INC. | ANDA040159 |
| 70518-4666-2 | 70518-4666 | Medroxyprogesterone Acetate Medroxyprogesterone Acetate | REMEDYREPACK INC. | ANDA040159 |
| 72789-043-30 | 72789-043 | Medroxyprogesterone Acetate Medroxyprogesterone Acetate | PD-Rx Pharmaceuticals, Inc. | ANDA040159 |
Drugs@FDA Applications#
| Application | NDC | Name | Marketing category | Labeler |
|---|---|---|---|---|
| ANDA040159 | 0555-0872 | Medroxyprogesterone Acetate Medroxyprogesterone Acetate | ANDA | Teva Pharmaceuticals USA, Inc. |
| NDA011839 | 59762-0055 | medroxyprogesterone acetate medroxyprogesterone acetate | NDA AUTHORIZED GENERIC | Mylan Pharmaceuticals Inc. |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Medroxyprogesterone Acetate | MEDROXYPROGESTERONE ACETATE | REMEDYREPACK INC. | 1020bb60-4f13-4cd7-aaa1-c556752c84b7 | 2026-08-31 | Warnings, Adverse reactions | 70518-4666-0 70518-4666-2 70518-4666 70518466600 70518466601 70518466602 1000135 |
| Provera | MEDROXYPROGESTERONE ACETATE | Pharmacia & Upjohn Company LLC | a586be28-96af-4fed-a13f-9b94fd4c7405 | 2026-06-29 | Boxed warning, Warnings, Adverse reactions | 1000135 |
| medroxyprogesterone acetate | MEDROXYPROGESTERONE ACETATE | Mylan Pharmaceuticals Inc. | 2627eb11-06bf-4a45-9172-094468e3ca07 | 2026-05-21 | Boxed warning, Warnings, Adverse reactions | 59762-0055-2 59762-0055-1 59762-0055 59762005501 59762005502 1000135 |
| Medroxyprogesterone Acetate | MEDROXYPROGESTERONE ACETATE | PD-Rx Pharmaceuticals, Inc. | 6a541749-5d14-44aa-a409-5e51f5bbf929 | 2025-10-02 | Boxed warning, Warnings, Adverse reactions | 72789-043-30 72789-043 72789004330 1000135 |
| Medroxyprogesterone Acetate | MEDROXYPROGESTERONE ACETATE | A-S Medication Solutions | 788df737-e990-4b5e-accd-af13c3b2bf8b | 2025-06-12 | Boxed warning, Warnings, Adverse reactions | 50090-0490-2 50090-0490 50090049000 50090049002 1000135 |
| Medroxyprogesterone Acetate | MEDROXYPROGESTERONE ACETATE | Coupler LLC | 2cf48919-6de8-d3d0-e063-6394a90ac1bc | 2025-01-30 | Boxed warning, Warnings, Adverse reactions | 67046-1480-3 67046-1480 67046148003 1000135 |
| Medroxyprogesterone Acetate | MEDROXYPROGESTERONE ACETATE | Bryant Ranch Prepack | d9ad130b-8f9a-4a0f-beb4-b692b6d3c5ca | 2024-07-08 | Boxed warning, Warnings, Adverse reactions | 63629-8825-1 63629-8825 63629882501 1000135 |
| Medroxyprogesterone Acetate | MEDROXYPROGESTERONE ACETATE | Teva Pharmaceuticals USA, Inc. | 9eb200b0-db96-4a51-87ea-04db862978c8 | 2024-03-01 | Boxed warning, Warnings, Adverse reactions | 0555-0872-04 0555-0872-02 0555-0872 00555087204 00555087202 1000135 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| d9ad130b-8f9a-4a0f-beb4-b692b6d3c5ca | medroxyPROGESTERone acetate 2.5 MG Oral Tablet [PSN] · medroxyprogesterone acetate 2.5 MG Oral Tablet [SCD] | 2 | 103 | MedroxyPROGESTERone Acetate Tablets, USP | 20240708 |
| 2627eb11-06bf-4a45-9172-094468e3ca07 | medroxyPROGESTERone acetate 2.5 MG Oral Tablet [PSN] · medroxyprogesterone acetate 2.5 MG Oral Tablet [SCD] | 2 | 33 | Medroxyprogesterone Acetate Tablets, USP | 20260521 |
| a586be28-96af-4fed-a13f-9b94fd4c7405 | medroxyPROGESTERone acetate 2.5 MG Oral Tablet [PSN] · medroxyprogesterone acetate 2.5 MG Oral Tablet [SCD] | 2 | 26 | PROVERA® (medroxyprogesterone acetate tablets, USP) | 20240830 |
| 6a541749-5d14-44aa-a409-5e51f5bbf929 | medroxyPROGESTERone acetate 2.5 MG Oral Tablet [PSN] · medroxyprogesterone acetate 2.5 MG Oral Tablet [SCD] | 2 | 20 | MedroxyPROGESTERone Acetate Tablets, USP | 20251002 |
| 9eb200b0-db96-4a51-87ea-04db862978c8 | medroxyPROGESTERone acetate 2.5 MG Oral Tablet [PSN] · medroxyprogesterone acetate 2.5 MG Oral Tablet [SCD] | 2 | 17 | MedroxyPROGESTERone Acetate Tablets, USP | 20240301 |
| 788df737-e990-4b5e-accd-af13c3b2bf8b | medroxyPROGESTERone acetate 2.5 MG Oral Tablet [PSN] · medroxyprogesterone acetate 2.5 MG Oral Tablet [SCD] | 2 | 14 | MedroxyPROGESTERone Acetate Tablets, USP | 20250612 |
| ec517411-6d3d-4cb1-a50e-f0818d03b0e4 | medroxyPROGESTERone acetate 2.5 MG Oral Tablet [PSN] · medroxyprogesterone acetate 2.5 MG Oral Tablet [SCD] | 2 | 8 | Medroxyprogesterone Acetate Tablets USP | 20140506 |
| 1020bb60-4f13-4cd7-aaa1-c556752c84b7 | medroxyPROGESTERone acetate 2.5 MG Oral Tablet [PSN] · medroxyprogesterone acetate 2.5 MG Oral Tablet [SCD] | 2 | 1 | MedroxyPROGESTERone Acetate Tablets, USP | 20260527 |
| 2cf48919-6de8-d3d0-e063-6394a90ac1bc | medroxyPROGESTERone acetate 2.5 MG Oral Tablet [PSN] · medroxyprogesterone acetate 2.5 MG Oral Tablet [SCD] | 2 | 1 | MedroxyPROGESTERone Acetate Tablets, USP | 20250130 |
| 1b67cd36-7199-42ff-a8a7-cecc81679676 | medroxyPROGESTERone acetate 2.5 MG Oral Tablet [PSN] · medroxyprogesterone acetate 2.5 MG Oral Tablet [SCD] | 2 | 1 | Medroxyprogesterone Acetate Tablets, USP | 20170317 |
| fda3368b-4ce3-4972-885d-066858831ee0 | medroxyPROGESTERone acetate 2.5 MG Oral Tablet [PSN] · medroxyprogesterone acetate 2.5 MG Oral Tablet [SCD] | 2 | 1 | Medroxyprogesterone Acetate Tablets USP | 20140113 |
| 499051ac-ffaf-4db4-be45-a409bd54991f | medroxyPROGESTERone acetate 2.5 MG Oral Tablet [PSN] · medroxyprogesterone acetate 2.5 MG Oral Tablet [SCD] | 2 | 1 | Medroxyprogesterone Acetate Tablets, USP | 20090813 |
Recently Linked DailyMed Labels#
| Set ID | Title | Manufacturer | Effective |
|---|---|---|---|
| 6a541749-5d14-44aa-a409-5e51f5bbf929 | MedroxyPROGESTERone Acetate Tablets, USP | PD-Rx Pharmaceuticals, Inc. | 20261014 |
| 1020bb60-4f13-4cd7-aaa1-c556752c84b7 | MedroxyPROGESTERone Acetate Tablets, USP | REMEDYREPACK INC. | 20260831 |
| 1020bb60-4f13-4cd7-aaa1-c556752c84b7 | MedroxyPROGESTERone Acetate Tablets, USP | REMEDYREPACK INC. | 20260527 |
| 2627eb11-06bf-4a45-9172-094468e3ca07 | Medroxyprogesterone Acetate Tablets, USP | Mylan Pharmaceuticals Inc. | Pfizer Inc | Pharmacia & Upjohn Company LLC | Pfizer Italia S.r.l. | 20260521 |
| 6a541749-5d14-44aa-a409-5e51f5bbf929 | MedroxyPROGESTERone Acetate Tablets, USP | PD-Rx Pharmaceuticals, Inc. | 20251002 |
| 788df737-e990-4b5e-accd-af13c3b2bf8b | MedroxyPROGESTERone Acetate Tablets, USP | A-S Medication Solutions | 20250612 |
| 2cf48919-6de8-d3d0-e063-6394a90ac1bc | MedroxyPROGESTERone Acetate Tablets, USP | Coupler LLC | 20250130 |
| 59cdc070-b4a2-1502-e053-2a91aa0a34fa | MedroxyPROGESTERone Acetate Tablets USP | NuCare Pharmaceuticals,Inc. | 20240716 |
| d9ad130b-8f9a-4a0f-beb4-b692b6d3c5ca | MedroxyPROGESTERone Acetate Tablets, USP | Bryant Ranch Prepack | 20240708 |
| 9eb200b0-db96-4a51-87ea-04db862978c8 | MedroxyPROGESTERone Acetate Tablets, USP | Teva Pharmaceuticals USA, Inc. | 20240301 |
| 0930a471-6ff1-43a1-b3ea-948ca3f99d06 | Medroxyprogesterone Acetate Tablets, USP | PD-Rx Pharmaceuticals, Inc. | 20220321 |
| 93b7c9e8-fa4a-4b6f-879f-d71fd251e349 | MedroxyPROGESTERone Acetate Tablets USP | Bryant Ranch Prepack | 20201016 |
| 1b67cd36-7199-42ff-a8a7-cecc81679676 | Medroxyprogesterone Acetate Tablets, USP | Avera McKennan Hospital | 20170317 |
| 43a33a55-a888-6d06-e054-00144ff8d46c | MedroxyPROGESTERone Acetate Tablets USP | NuCare Pharmaceuticals, Inc. | 20161214 |
| ec517411-6d3d-4cb1-a50e-f0818d03b0e4 | Medroxyprogesterone Acetate Tablets USP | ReadyMeds | 20140506 |
| fda3368b-4ce3-4972-885d-066858831ee0 | Medroxyprogesterone Acetate Tablets USP | Aidarex Pharmaceuticals LLC | 20140113 |
| 72a8e114-a287-4552-b1d2-eccd7d7b5ef2 | National Council for Prescription Drug Programs | 20130213 | |
| 7be7727e-59cd-405e-985b-8fcbaf4c8dbe | National Council for Prescription Drug Programs | 20130213 | |
| a2eec61a-10c2-4e14-81ad-c43a3b2d699f | National Council for Prescription Drug Programs | 20130213 | |
| aab0090b-41ce-45cc-bcf0-013fd0ae8492 | National Council for Prescription Drug Programs | 20130213 | |
| bb39f524-8699-4b72-90aa-d937155ca9ef | National Council for Prescription Drug Programs | 20130213 | |
| d6c3fd4c-db6c-40d6-998c-115f96e7d005 | National Council for Prescription Drug Programs | 20130213 | |
| 05e8d852-8792-4052-a20e-4119a8c39207 | National Council for Prescription Drug Programs | 20130213 | |
| eb1010d2-6b62-4ed8-81f9-f2489c03047b | National Council for Prescription Drug Programs | 20130213 | |
| 282c5ee9-6dbe-4ff8-b54d-5a4858c4faed | National Council for Prescription Drug Programs | 20120724 | |
| 800a95f3-43ef-4611-9780-22993399d3d3 | National Council for Prescription Drug Programs | 20120724 | |
| 8f90eada-95c8-48fa-b74b-2e37cd692a6f | National Council for Prescription Drug Programs | 20120724 | |
| 299323d8-e9c6-42fe-a833-5dd18c8ac8de | National Council for Prescription Drug Programs | 20120724 | |
| b055d384-8df3-4aed-88a1-5dddd52e0bdc | National Council for Prescription Drug Programs | 20120724 | |
| 499051ac-ffaf-4db4-be45-a409bd54991f | Medroxyprogesterone Acetate Tablets, USP | Physicians Total Care, Inc. | 20090813 |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | G03DA | Pregnen (4) derivatives | ATC1-4 | medroxyprogesterone | |
| ATC | L02AB | Progestogens | ATC1-4 | medroxyprogesterone | |
| ATC | G03AC | Progestogens | ATC1-4 | medroxyprogesterone | |
| FDASPL | D045167 | Progesterone Congeners | CHEM | has_chemical_structure | medroxyprogesterone |
| FDASPL | N0000175602 | Progestin | EPC | has_epc | medroxyprogesterone |
| MEDRT | D008525 | Medroxyprogesterone | CHEM | has_ingredient | medroxyprogesterone |
| MEDRT | D017258 | Medroxyprogesterone Acetate | CHEM | has_ingredient | medroxyprogesterone acetate |
| MEDRT | D000568 | Amenorrhea | DISEASE | may_treat | medroxyprogesterone acetate |
| MEDRT | D000568 | Amenorrhea | DISEASE | may_treat | medroxyprogesterone |
| MEDRT | D001943 | Breast Neoplasms | DISEASE | may_treat | medroxyprogesterone |
| MEDRT | D001943 | Breast Neoplasms | DISEASE | ci_with | medroxyprogesterone |
| MEDRT | D001943 | Breast Neoplasms | DISEASE | ci_with | medroxyprogesterone acetate |
| MEDRT | D001943 | Breast Neoplasms | DISEASE | may_treat | medroxyprogesterone acetate |
| MEDRT | D002292 | Carcinoma, Renal Cell | DISEASE | may_treat | medroxyprogesterone acetate |
| MEDRT | D002292 | Carcinoma, Renal Cell | DISEASE | may_treat | medroxyprogesterone |
| MEDRT | D002543 | Cerebral Hemorrhage | DISEASE | ci_with | medroxyprogesterone acetate |
| MEDRT | D002543 | Cerebral Hemorrhage | DISEASE | ci_with | medroxyprogesterone |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | medroxyprogesterone acetate |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | medroxyprogesterone |
| MEDRT | D004714 | Endometrial Hyperplasia | DISEASE | may_treat | medroxyprogesterone acetate |
| MEDRT | D004714 | Endometrial Hyperplasia | DISEASE | may_treat | medroxyprogesterone |
| MEDRT | D016889 | Endometrial Neoplasms | DISEASE | may_treat | medroxyprogesterone |
| MEDRT | D016889 | Endometrial Neoplasms | DISEASE | may_treat | medroxyprogesterone acetate |
| MEDRT | D006470 | Hemorrhage | DISEASE | ci_with | medroxyprogesterone |
| MEDRT | D006470 | Hemorrhage | DISEASE | ci_with | medroxyprogesterone acetate |
| MEDRT | D007040 | Hypoventilation | DISEASE | may_treat | medroxyprogesterone |
| MEDRT | D007040 | Hypoventilation | DISEASE | may_treat | medroxyprogesterone acetate |
| MEDRT | D008107 | Liver Diseases | DISEASE | ci_with | medroxyprogesterone acetate |
| MEDRT | D008107 | Liver Diseases | DISEASE | ci_with | medroxyprogesterone |
| MEDRT | D009376 | Neoplasms, Hormone-Dependent | DISEASE | ci_with | medroxyprogesterone acetate |
| MEDRT | D009376 | Neoplasms, Hormone-Dependent | DISEASE | ci_with | medroxyprogesterone |
| MEDRT | D011247 | Pregnancy | DISEASE | may_prevent | medroxyprogesterone acetate |
| MEDRT | D011247 | Pregnancy | DISEASE | may_prevent | medroxyprogesterone |
| MEDRT | D011247 | Pregnancy | DISEASE | ci_with | medroxyprogesterone |
| MEDRT | D011247 | Pregnancy | DISEASE | ci_with | medroxyprogesterone acetate |
| MEDRT | D011655 | Pulmonary Embolism | DISEASE | ci_with | medroxyprogesterone acetate |
| MEDRT | D011655 | Pulmonary Embolism | DISEASE | ci_with | medroxyprogesterone |
| MEDRT | D013924 | Thrombophlebitis | DISEASE | ci_with | medroxyprogesterone acetate |
| MEDRT | D013924 | Thrombophlebitis | DISEASE | ci_with | medroxyprogesterone |
| MEDRT | D014592 | Uterine Hemorrhage | DISEASE | ci_with | medroxyprogesterone |
| MEDRT | D014592 | Uterine Hemorrhage | DISEASE | ci_with | medroxyprogesterone acetate |
| MEDRT | D014592 | Uterine Hemorrhage | DISEASE | may_treat | medroxyprogesterone acetate |
| MEDRT | D014592 | Uterine Hemorrhage | DISEASE | may_treat | medroxyprogesterone |
| MEDRT | D014623 | Vaginal Diseases | DISEASE | ci_with | medroxyprogesterone |
| MEDRT | D014623 | Vaginal Diseases | DISEASE | ci_with | medroxyprogesterone acetate |
| MEDRT | D020246 | Venous Thrombosis | DISEASE | ci_with | medroxyprogesterone |
| MEDRT | D020246 | Venous Thrombosis | DISEASE | ci_with | medroxyprogesterone acetate |
| MEDRT | N0000000185 | Progestational Hormone Receptor Agonists | MOA | has_moa | medroxyprogesterone acetate |
| MEDRT | N0000000185 | Progestational Hormone Receptor Agonists | MOA | has_moa | medroxyprogesterone |
| MEDRT | N0000008630 | Decreased Follicle Stimulating Hormone Secretion | PE | has_pe | medroxyprogesterone acetate |
| MEDRT | N0000008630 | Decreased Follicle Stimulating Hormone Secretion | PE | has_pe | medroxyprogesterone |
| MEDRT | N0000008632 | Decreased Growth Hormone Secretion | PE | has_pe | medroxyprogesterone acetate |
| MEDRT | N0000008632 | Decreased Growth Hormone Secretion | PE | has_pe | medroxyprogesterone |
| MEDRT | N0000009051 | Gonadotropin Releasing Hormone Alteration | PE | has_pe | medroxyprogesterone acetate |
| MEDRT | N0000009051 | Gonadotropin Releasing Hormone Alteration | PE | has_pe | medroxyprogesterone |
| MEDRT | N0000009715 | Inhibit Ovarian Follicular Phase | PE | has_pe | medroxyprogesterone acetate |
| MEDRT | N0000009715 | Inhibit Ovarian Follicular Phase | PE | has_pe | medroxyprogesterone |
| MEDRT | N0000009717 | Inhibit Ovulation | PE | has_pe | medroxyprogesterone acetate |
| MEDRT | N0000009717 | Inhibit Ovulation | PE | has_pe | medroxyprogesterone |
| MEDRT | N0000009857 | Stimulate Breast Glandular Development | PE | has_pe | medroxyprogesterone acetate |
| MEDRT | N0000009857 | Stimulate Breast Glandular Development | PE | has_pe | medroxyprogesterone |
| MEDRT | N0000000043 | Hepatic Excretion | PK | has_pk | medroxyprogesterone |
| MEDRT | N0000000043 | Hepatic Excretion | PK | has_pk | medroxyprogesterone acetate |
| MEDRT | N0000000026 | Hepatic Metabolism | PK | has_pk | medroxyprogesterone |
| MEDRT | N0000000026 | Hepatic Metabolism | PK | has_pk | medroxyprogesterone acetate |
| MEDRT | N0000000042 | Renal Excretion | PK | has_pk | medroxyprogesterone |
| MEDRT | N0000000042 | Renal Excretion | PK | has_pk | medroxyprogesterone acetate |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | AVAILABLE_STRENGTH | 2.5 MG (expressed as medroxyprogesterone acetate) |
| ATTRIBUTES | GENERAL_CARDINALITY | SINGLE |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | SCHEDULE | 0 |
| CODES | ANDA | ANDA040159 |
| CODES | SNOMEDCT | 325603009 |
| CODES | VUID | 4002353 |
| NAMES | Prescribable Synonym | medroxyPROGESTERone acetate 2.5 MG Oral Tablet |
| NAMES | Tallman Synonym | medroxyPROGESTERone acetate 2.5 MG Oral Tablet |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |
| SOURCES | Source | Micromedex RED BOOK |
| SOURCES | Source | Multum MediSource Lexicon |
| SOURCES | Source | National Drug Data File Plus Source Vocabulary |
| SOURCES | Source | US Edition of SNOMED_CT |
| SOURCES | Source | Veterans Health Administration National Drug File |